Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective-Reference-Cited by-同舟云学术

Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective

Published:2023-12 Issue: Volume: Page:
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

de Jong Amos J.,Shahid Nadi,Zuidgeest Mira G.P.,Santa-Ana-Tellez Yared,Hogervorst Milou,Goettsch Wim,Traore Hamidou,de Boer Anthonius,Gardarsdottir Helga

Funder

Innovative Medicines Initiative

European Federation of Pharmaceutical Industries and Associations

IMI

Horizon 2020 Framework Programme

Horizon 2020

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. Is there a European view on health economic evaluations? Results from a synopsis of methodological guidelines used in the EUnetHTA partner countries;Heintz;Pharmacoeconomics,2016

2. Quantifying the use of connected digital products in clinical research;Marra;NPJ Digit Med,2020

3. Use of mobile devices to measure outcomes in clinical research, 2010-2016: a systematic literature review;Perry;Digit Biomark,2018

4. Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials;Noah;NPJ Digit Med,2018

5. Using e-technologies in clinical trials;Rosa;Contemp Clin Trials,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-compassion-based online group psychotherapy for bereavement-related grief: The COMPACT feasibility trial;General Hospital Psychiatry;2024-09

2. Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches;Drug Discovery Today;2024-09

3. Advancing Rheumatology Care Through Machine Learning;Pharmaceutical Medicine;2024-02-29